ObesityNCT02585518
Ecological Momentary Assessment of Eating Behavior in Overweight Youth
An observational study of Obesity, run by University of Chicago at 1 site in United States.
Trial summary
The current study seeks to elucidate the context of pathological and non-pathological eating behavior in a heterogeneous sample of overweight and obese children, aged 8-14 years. Read more about this study
- Who is it for?
- Ages 8 to 14 yearsHealthy volunteers can take part
- Conditions the study is for
- Obesity
- How many people
- 44 participants
- Where
- 1 siteUnited States
- Study dates
- Feb 2015to 1 May 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 8 to 14 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: Participants will comprise 40 overweight or obese (BMI≥85th %ile) youth aged 8-14 years. Every effort will be made to recruit a racially/ethnically diverse sample. Participants will be excluded if they 1) are currently taking any medications known to affect weight or appetite (e.g., antidepressants, steroids, chemotherapy drugs); 2) have a current or past diagnosis of an eating disorder involving purging or suppressed body weight (e.g., bulimia nervosa or anorexia nervosa); 3) are unable to read and understand English fluently; or 4) are receiving concurrent treatment for obesity.
Who may be able to join
- Participants be included if they are overweight or obese (BMI≥85th %ile) and aged 8-14 years.
Who cannot join
- Participants will be excluded if they 1) are currently taking any medications known to affect weight or appetite (e.g., antidepressants, steroids, chemotherapy drugs); 2) have a current or past diagnosis of an eating disorder involving purging or suppressed body weight (e.g., bulimia nervosa or anorexia nervosa); 3) are unable to read and understand English fluently; or 4) are receiving concurrent treatment for obesity.
Trial locations and contacts
1 site in 1 country.
About this study
The current study seeks to elucidate the context of pathological and non-pathological eating behavior in a heterogeneous sample of overweight and obese children, aged 8-14 years. Children will undergo a two-week ecological momentary assessment (EMA) protocol in which they record all eating episodes and their physiological, emotional, interpersonal, and environmental correlates. Specific aims are to identify proximal antecedents and consequences of pathological and non-pathological eating in overweight and obese children, and to determine the prevalence of loss of control eating in the natural environment.
Read the detailed description
Interested individuals will be screened via phone for initial study eligibility. Potentially eligible participants and their parents will attend an in-person screening at the University of Chicago in which they will complete assent and consent procedures. Youth will have their height and weight measured and complete interviews to assess eating disorder symptoms and psychiatric comorbidities. Eligible participants and parents will then complete self- and parent-report assessments of eating behavior, body image concerns, psychiatric symptoms, and interpersonal functioning. Participants will then be trained on how to complete the EMA recordings.
A one-day practice period during which adherence is ≥70% of ratings will qualify children to initiate the 14-day EMA study period; these data will not be used in statistical analyses to reduce concerns about the effect of immediate reactivity to self-monitoring. Youth will self-monitor on a smartphone or other wireless device through the use of the ReTAINE (Real-Time Assessment in the Natural Environment) system. ReTAINE™ is a secure, web-based system that allows for momentary data to be collected through a wide variety of portable devices. Youth may use their own smartphone/wireless device or one provided by the study team. Recent survey data suggest that up to 80% of children and adolescents have access to the Internet through a cellular phone or other wireless device, indicating that this approach is reasonable in this age group. EMA protocols have been completed with good compliance in youth.
The proposed study will include three types of EMA signaling methods.63 First, participants will be signaled at 3-5 semi-random times throughout the day (signal-contingent) to report on current affect, stressors, interpersonal functioning, and to report any eating episode that has not been previously recorded. These signals will occur at random times between 7:00-8:00am, 3:00-4:00pm, and 6:00-7:00pm on weekdays, so as not to interfere with the school day; and between 8:00-9:00am, 11:00am-12:00pm, 2:00-3:00pm, 5:00-6:00pm, and 8:00-9:00pm on weekend days. In addition, participants will be instructed to complete momentary ratings of affect, stressors, interpersonal functioning, and a variety of physiological, environmental, cognitive, and behavioral factors associated with eating as soon after each eating episode as possible (event-contingent). Event-contingent ratings will allow for the assessment of immediate consequences of eating that may be missed by the random signals. Finally, participants will complete ratings of affect, stressors, interpersonal functioning, and physiological, environmental, cognitive, and behavioral factors at the end of each day (interval-contingent) to capture any changes since the last random signal. This combination of signal-, event-, and interval- contingent recordings has been successfully implemented in previous EMA studies of overweight youth.
Participants will be contacted by phone after the first day of EMA recording, at which point they will be given feedback regarding their compliance rates, and any questions or concerns regarding assessment procedures will be discussed with a research assistant. Throughout the 14-day assessment period, we will also attempt to contact participants via telephone at least twice per week to check in with them regarding any problems or concerns. This approach has demonstrated success in participant retention and validated compliance during a previous research study which required daily collection of saliva samples and interval ratings of mood and disordered eating behaviors over 35 days.
Complementary to the collection of EMA data, Nutritional Data System for Research (NDS-R)65 will be used to compile nutritional intake data on eating episodes reported by participants through the ReTAINE system. Two weekdays and one weekend day during the 14-day protocol will be randomly selected for each participant, during which the participant will be contacted by phone and asked to recall the details of each of that day's eating episodes. The time points of each eating episode will be entered into the NDS-R system, and the nutritional data of interest will be merged with the EMA data in order to assess contextual factors associated with specific dietary patterns (e.g., consumption of high fat meals). ActiGraph watches (GT3X) will be worn by participants for the duration of the 14-day protocol to compile data on sleep patterns in the natural home environment. These computerized wristwatch-like devices collect data generated by movement and are minimally invasive. Participants' parents will also complete 14-day sleep diaries in which they will record their children's bedtime and wake time, which will provide the start and end times for actigraphy analyses.
At the completion of the daily assessment phase, participants will return to the University of Chicago to return the loaner smartphone, if applicable; complete a brief, final assessment; and receive their final study incentive payments. The final assessment will include a modified version of the Child Eating Disorder Examination (ChEDE) interview to cover the previous two weeks during which EMA was conducted. This assessment will be used to determine changes in symptom frequency (i.e., reactivity to study procedures).
- Conditions
- Obesity
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Obese | Children and adolescents with a BMI at or above the 85th percentile for age and sex | |
| Healthy control | Children and adolescents with a BMI below the 85th percentile for age and sex |
What is being measured
The primary outcome is the main question the study is designed to answer.
Eating episodes
Measured: Repeated measures throughout the 2-week EMA protocol
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2015 (estimated)
- Study startFeb 2015
- Primary completion21 Jan 2017
- Study completion1 May 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- More trials run by University of ChicagoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Chicago
- Sponsor type
- University, hospital or other
- Collaborators
- Illinois Institute of Technology, University of North Dakota
- Responsible party
- Sponsor
- Investigators
- Andrea Goldschmidt, PhD, Principal investigator, University of Chicago
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02585518
- Sponsor's protocol ID
- IRB14-1212
- Status last verified
- May 2024
- First submitted
- 21 Oct 2015
- Last updated
- 7 May 2024
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ecological Momentary Assessment of Eating Behavior in Overweight Youth
- ClinicalTrials.gov ID
- NCT02585518
- Acronym / sponsor ID
- IRB14-1212
- Conditions
- Obesity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 44 participants (actual)
- Lead sponsor
- University of ChicagoUniversity, hospital or other
- Collaborators
- Illinois Institute of Technology, University of North Dakota
- Study start
- Feb 2015
- Primary completion
- 21 Jan 2017 (actual)
- Study completion
- 1 May 2017 (actual)
- First posted
- 23 Oct 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The current study seeks to elucidate the context of pathological and non-pathological eating behavior in a heterogeneous sample of overweight and obese children, aged 8-14 years. Children will undergo a two-week ecological momentary assessment (EMA) protocol in which they record all eating episodes and their physiological, emotional, interpersonal, and environmental correlates. Specific aims are to identify proximal antecedents and consequences of pathological and non-pathological eating in overweight and obese children, and to determine the prevalence of loss of control eating in the natural environment.
Detailed description
Interested individuals will be screened via phone for initial study eligibility. Potentially eligible participants and their parents will attend an in-person screening at the University of Chicago in which they will complete assent and consent procedures. Youth will have their height and weight measured and complete interviews to assess eating disorder symptoms and psychiatric comorbidities. Eligible participants and parents will then complete self- and parent-report assessments of eating behavior, body image concerns, psychiatric symptoms, and interpersonal functioning. Participants will then be trained on how to complete the EMA recordings.
A one-day practice period during which adherence is ≥70% of ratings will qualify children to initiate the 14-day EMA study period; these data will not be used in statistical analyses to reduce concerns about the effect of immediate reactivity to self-monitoring. Youth will self-monitor on a smartphone or other wireless device through the use of the ReTAINE (Real-Time Assessment in the Natural Environment) system. ReTAINE™ is a secure, web-based system that allows for momentary data to be collected through a wide variety of portable devices. Youth may use their own smartphone/wireless device or one provided by the study team. Recent survey data suggest that up to 80% of children and adolescents have access to the Internet through a cellular phone or other wireless device, indicating that this approach is reasonable in this age group. EMA protocols have been completed with good compliance in youth.
The proposed study will include three types of EMA signaling methods.63 First, participants will be signaled at 3-5 semi-random times throughout the day (signal-contingent) to report on current affect, stressors, interpersonal functioning, and to report any eating episode that has not been previously recorded. These signals will occur at random times between 7:00-8:00am, 3:00-4:00pm, and 6:00-7:00pm on weekdays, so as not to interfere with the school day; and between 8:00-9:00am, 11:00am-12:00pm, 2:00-3:00pm, 5:00-6:00pm, and 8:00-9:00pm on weekend days. In addition, participants will be instructed to complete momentary ratings of affect, stressors, interpersonal functioning, and a variety of physiological, environmental, cognitive, and behavioral factors associated with eating as soon after each eating episode as possible (event-contingent). Event-contingent ratings will allow for the assessment of immediate consequences of eating that may be missed by the random signals. Finally, participants will complete ratings of affect, stressors, interpersonal functioning, and physiological, environmental, cognitive, and behavioral factors at the end of each day (interval-contingent) to capture any changes since the last random signal. This combination of signal-, event-, and interval- contingent recordings has been successfully implemented in previous EMA studies of overweight youth.
Participants will be contacted by phone after the first day of EMA recording, at which point they will be given feedback regarding their compliance rates, and any questions or concerns regarding assessment procedures will be discussed with a research assistant. Throughout the 14-day assessment period, we will also attempt to contact participants via telephone at least twice per week to check in with them regarding any problems or concerns. This approach has demonstrated success in participant retention and validated compliance during a previous research study which required daily collection of saliva samples and interval ratings of mood and disordered eating behaviors over 35 days.
Complementary to the collection of EMA data, Nutritional Data System for Research (NDS-R)65 will be used to compile nutritional intake data on eating episodes reported by participants through the ReTAINE system. Two weekdays and one weekend day during the 14-day protocol will be randomly selected for each participant, during which the participant will be contacted by phone and asked to recall the details of each of that day's eating episodes. The time points of each eating episode will be entered into the NDS-R system, and the nutritional data of interest will be merged with the EMA data in order to assess contextual factors associated with specific dietary patterns (e.g., consumption of high fat meals). ActiGraph watches (GT3X) will be worn by participants for the duration of the 14-day protocol to compile data on sleep patterns in the natural home environment. These computerized wristwatch-like devices collect data generated by movement and are minimally invasive. Participants' parents will also complete 14-day sleep diaries in which they will record their children's bedtime and wake time, which will provide the start and end times for actigraphy analyses.
At the completion of the daily assessment phase, participants will return to the University of Chicago to return the loaner smartphone, if applicable; complete a brief, final assessment; and receive their final study incentive payments. The final assessment will include a modified version of the Child Eating Disorder Examination (ChEDE) interview to cover the previous two weeks during which EMA was conducted. This assessment will be used to determine changes in symptom frequency (i.e., reactivity to study procedures).
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Obese | – | –Children and adolescents with a BMI at or above the 85th percentile for age and sex |
| Healthy control | – | –Children and adolescents with a BMI below the 85th percentile for age and sex |
Who may qualify
- Ages
- 8 to 14 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- Participants will comprise 40 overweight or obese (BMI≥85th %ile) youth aged 8-14 years. Every effort will be made to recruit a racially/ethnically diverse sample. Participants will be excluded if they 1) are currently taking any medications known to affect weight or appetite (e.g., antidepressants, steroids, chemotherapy drugs); 2) have a current or past diagnosis of an eating disorder involving purging or suppressed body weight (e.g., bulimia nervosa or anorexia nervosa); 3) are unable to read and understand English fluently; or 4) are receiving concurrent treatment for obesity.
Key inclusion criteria (1 listed)
- Participants be included if they are overweight or obese (BMI≥85th %ile) and aged 8-14 years.
Key exclusion criteria (1 listed)
- Participants will be excluded if they 1) are currently taking any medications known to affect weight or appetite (e.g., antidepressants, steroids, chemotherapy drugs); 2) have a current or past diagnosis of an eating disorder involving purging or suppressed body weight (e.g., bulimia nervosa or anorexia nervosa); 3) are unable to read and understand English fluently; or 4) are receiving concurrent treatment for obesity.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Eating episodes
Time frame: Repeated measures throughout the 2-week EMA protocol
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 May 2024.
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andrea Goldschmidt, PhD principal investigator
University of Chicago
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Obesity, run by University of Chicago at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Eating episodes (time frame: Repeated measures throughout the 2-week EMA protocol). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2024.